The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Publications
Appearance of ANCA - associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment.
The American journal of case reports 2013;14;80-2 — 2013 — 80-2
Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sörensen H, Zeidler H, Thriene W, Sieper J
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.
Lancet (London, England) 2002 Apr 06;359;1187-93 — 2002 Apr 06 — 1187-93